Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-21-129591
Filing Date
2021-10-25
Accepted
2021-10-25 17:30:06
Documents
4
Period of Report
2021-12-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2130904-1_pre14a.htm PRE 14A 628426
2 GRAPHIC sg_jillmilne-bw.jpg GRAPHIC 7184
3 GRAPHIC tm2130904d1-px_01cardbw.jpg GRAPHIC 775841
4 GRAPHIC tm2130904d1-px_02cardbw.jpg GRAPHIC 1232962
  Complete submission text file 0001104659-21-129591.txt   3402712
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37467 | Film No.: 211345123
SIC: 2834 Pharmaceutical Preparations